Earnings

Encompass Health Raises FY2026 Adj EPS Guidance from $6.02-$6.25 to $6.23-$6.37 vs $6.11 Est; Raises FY2026 Sales Guidance from $6.410B-$6.490B to $6.450B-$6.500B vs $6.460B Est

Oct 28, 2026 · 04:34 PM ET· updated 1h ago

Encompass Health (NYSE:EHC) raises FY2026 Adj EPS guidance from $6.02-$6.25 to $6.23-$6.37 vs $6.11 analyst estimate. Raises FY2026 sales outlook from $6.410 billion-$6.490 billion to $6.450 billion-$6.500 billion vs

Why It Matters

Encompass Health expects to make more money next year than it thought before. This shows the company is doing better, so watch if the business keeps growing strong.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

EHC120.00

-1.53 (-1.26%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.